lisuride has been researched along with vasoactive intestinal peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attard, M; Ghataorhe, P; Lythgoe, MP; Rhodes, CJ; Wharton, J; Wilkins, MR | 1 |
1 review(s) available for lisuride and vasoactive intestinal peptide
| Article | Year |
|---|---|
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future.
Topics: Animals; Biomarkers; Clinical Studies as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Lisuride; Phenotype; Phentolamine; Protein-Tyrosine Kinases; Vasoactive Intestinal Peptide | 2016 |